Network origin in Frank Waligora first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
22
| Public Company | Biotechnology | 22 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Frank Waligora via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
| The Johns Hopkins University | College/University | Director/Board Member Corporate Officer/Principal Graduate Degree | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| Yale University | College/University | Corporate Officer/Principal Masters Business Admin | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Comptroller/Controller/Auditor | |
| Boston College | College/University | Undergraduate Degree Graduate Degree | |
| University of Michigan | College/University | Doctorate Degree Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
ACT Biotech, Inc.
 ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Xequel Bio, Inc.
 Xequel Bio, Inc. Pharmaceuticals: MajorHealth Technology Xequel Bio, Inc. operates as a biopharmaceutical company. It develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration. The company was founded by Gautam Sudhir Ghatnekar in 2005 and is headquartered in Mount Pleasant, SC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| CUE BIOPHARMA, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| LOXO ONCOLOGY INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| XENCOR, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| DNAX Research, Inc. | Corporate Officer/Principal | ||
| University of California San Diego | College/University | Undergraduate Degree | |
| Central South University | College/University | Corporate Officer/Principal | |
| XOMA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| IMUNON, INC. | Biotechnology | Director/Board Member | |
CytoMed, Inc.
 CytoMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Doctorate Degree | |
| All India Institute of Medical Sciences | College/University | Graduate Degree | |
| Immtox LLC | Founder | ||
| CARA THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| Axon Healthcare Ltd. | Corporate Officer/Principal | ||
SAB Sciences, Inc.
 SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | Pharmaceuticals: Major | Director/Board Member | |
| CereXis, Inc. | Chief Executive Officer | ||
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member | |
Novasenta, Inc.
 Novasenta, Inc. Miscellaneous Commercial ServicesCommercial Services Novasenta, Inc. develops therapies for cancer. The company is based in Pittsburgh, PA. The company was founded by Greg Delgoffe, Robert L. Ferris, Dario Vignali. Mani Mohindru has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Chief Executive Officer | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| E I DU PONT DE NEMOURS AND CO | Chemicals: Agricultural | Corporate Officer/Principal | |
| VALERITAS INC | Medical Specialties | Director of Finance/CFO | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 48 |
| India | 3 |
| China | 2 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 12 |
| Finance | 3 |
| Commercial Services | 2 |
| Process Industries | 2 |
Operational
| Director/Board Member | 77 |
| Corporate Officer/Principal | 62 |
| Chief Tech/Sci/R&D Officer | 25 |
| Independent Dir/Board Member | 25 |
| Doctorate Degree | 16 |
Most connected contacts
| Insiders | |
|---|---|
| Lori Kunkel | 27 |
| James Tobin | 26 |
| Susan B. Bayh | 20 |
| Robert Martell | 18 |
| Joseph M. Davie | 17 |
| Mani Mohindru | 15 |
| James McNab | 14 |
| Michael Gray | 12 |
| Ali Fattaey | 10 |
| Daniel Passeri | 9 |
| James Dentzer | 9 |
| Kenneth J. Pienta | 8 |
| David Tuck | 7 |
| Mitchell Keegan | 6 |
| Changgeng Qian | 5 |
- Stock Market
- Insiders
- Frank Waligora
- Company connections
